Camurus AB Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Camurus AB

Camurus AB | Mutual Funds

Mutual Funds that own Camurus AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Gladiator

1,384,025

3.61%

1,384,025

2.67%

12/31/2016

Catella Sverige Select

1,062,824

2.77%

-6,767

1.55%

08/31/2018

Folksams LO Sverige

965,323

2.52%

0.23%

07/31/2018

Fjarde AP Fonden

765,332

1.99%

765,332

0.02%

12/31/2016

304,657

0.79%

-1,396

0.35%

08/31/2018

269,703

0.7%

-1,236

0.54%

08/31/2018

Enter Select Pro

235,500

0.61%

18,000

1.17%

12/31/2017

Enter Select

198,298

0.52%

15,100

1.18%

12/31/2017

KPA Etisk Aktiefond

172,110

0.45%

0.23%

07/31/2018

Enter Sverige

144,630

0.38%

4,000

1.04%

09/30/2016

About Camurus AB

View Profile

Address	Ideon Science Park Lund SN 223 70 Sweden
Employees	-
Website	http://www.camurus.com
Updated	07/08/2019
Camurus AB engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer, and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.